Pathology revealed a neuroendocrine carcinoma (NEC) that was positive for synaptophysin and CEA, with a Ki-67 index of 30% (Figure 3), and negative for chromogranin A and CD56. The gene discussed is NCAM1; the disease is neuroendocrine carcinoma.